文献速递肝病消化内镜

新冠后胆管病:一种新疾病实体

Post-COVID-19 Cholangiopathy: A Novel Entity.
PubMed 文献 · Am J Gastroenterol · 2021-01-01

本文描述3例重症心肺型COVID-19康复期出现迁延且严重胆汁淤积的成人患者,其临床与组织学特征类似危重患者继发性硬化性胆管炎,但具有独特组织学表现,包括严重胆管细胞损伤和肝内微血管病,提示COVID-19直接肝损伤,作者认为这构成一种新型严重新冠后胆管病,可能导致长期肝脏病变。

要点

  • 重症COVID-19康复期可出现迁延严重胆汁淤积,需警惕新冠后胆管病。
  • 组织学可见严重胆管细胞损伤和肝内微血管病,提示直接肝损伤。
  • 该病有长期肝脏病变风险,需随访肝功能与胆管影像。

核心结论

  • 3例重症心肺型COVID-19康复期患者出现迁延严重胆汁淤积,构成一种新型严重新冠后胆管病,具有长期肝脏病变风险。

研究设计与样本

  • 描述性病例系列,纳入3例从重症心肺型COVID-19康复的成人患者,报告临床病程与组织学特征。

主要发现

  • 患者出现迁延且严重的胆汁淤积。
  • 临床与组织学特征类似危重患者继发性硬化性胆管炎。
  • 组织学具有严重胆管细胞损伤和肝内微血管病等独特表现,提示COVID-19直接肝损伤。

关键数值与推荐

  • 肝化学异常是COVID-19常见表现,通常短暂并随疾病缓解而消退。

临床怎么用

  • 对重症COVID-19康复期出现迁延严重胆汁淤积者,应评估新冠后胆管病并关注长期肝脏病变。

局限性

  • 仅基于3例成人患者的描述性病例系列,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Liver chemistry abnormalities are a frequent manifestation of coronavirus disease 2019 (COVID-19) but are usually transient and resolve with disease resolution. METHODS: We describe the clinical course and histologic features of 3 adults who developed prolonged and severe cholestasis during recovery from critical cardiopulmonary COVID-19. RESULTS: These patients had clinical and histologic features similar to secondary sclerosing cholangitis of the critically ill patient, but with unique histologic features including severe cholangiocyte injury and intrahepatic microangiopathy suggestive of direct hepatic injury from COVID-19. DISCUSSION: We believe that these cases constitute a novel severe post-COVID-19 cholangiopathy with potential for long-term hepatic morbidity.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 Cholangiopathy: A Novel Entity. Am J Gastroenterol. 2021. PMID: 33464757. doi:10.14309/ajg.0000000000001154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。